Results 311 to 320 of about 693,546 (355)
Some of the next articles are maybe not open access.
NeuroToxicology, 2022
Parkinson's disease (PD) and carbon monoxide (CO) poisoning demonstrate parkinsonian features related to presynaptic dopaminergic deficits. However, their clinical features and treatment responses are different, indicating other roles of neurotransmitters in symptomatic modulation.
Ing-Tsung Hsiao +6 more
openaire +2 more sources
Parkinson's disease (PD) and carbon monoxide (CO) poisoning demonstrate parkinsonian features related to presynaptic dopaminergic deficits. However, their clinical features and treatment responses are different, indicating other roles of neurotransmitters in symptomatic modulation.
Ing-Tsung Hsiao +6 more
openaire +2 more sources
Exercise as medicine in Parkinson’s disease
Journal of Neurology Neurosurgery & PsychiatryParkinson’s disease (PD) is an incurable and progressive neurological disorder leading to deleterious motor and non-motor consequences. Presently, no pharmacological agents can prevent PD evolution or progression, while pharmacological symptomatic ...
M. Langeskov-Christensen +3 more
semanticscholar +1 more source
Journal of Parkinson's Disease, 2021
Background: In Parkinson’s disease (PD), sustained aerobic exercise is a promising therapy in delaying motor disability. Brisk walking is a moderate intensity aerobic training, which could be translated to community practice at low cost, but its effects ...
M. Mak, I. S. Wong-Yu
semanticscholar +1 more source
Background: In Parkinson’s disease (PD), sustained aerobic exercise is a promising therapy in delaying motor disability. Brisk walking is a moderate intensity aerobic training, which could be translated to community practice at low cost, but its effects ...
M. Mak, I. S. Wong-Yu
semanticscholar +1 more source
Neuroscience Letters, 2019
The microbiota of individuals with Parkinson's disease (PD) has been the focus of research in recent years. However, the mechanisms underlying the interactions between the gut microbiome and the brain, as well as its role in PD pathogenesis, remain to be elucidated.
Shengqin, Wang +3 more
openaire +2 more sources
The microbiota of individuals with Parkinson's disease (PD) has been the focus of research in recent years. However, the mechanisms underlying the interactions between the gut microbiome and the brain, as well as its role in PD pathogenesis, remain to be elucidated.
Shengqin, Wang +3 more
openaire +2 more sources
Othello Syndrome Secondary to Subthalamic Deep Brain Stimulation in Parkinson’s Disease
Journal of Neuropsychiatry, 2017Deep brain stimulation (DBS) is established method of Parkinson’s disease(PD) treatment. The stimulation of the limbic portion of subthalamic nucleus (STN) might devise psychotic symptoms. PD psychosis may be related also to drug intake, especially dopamine agonists(DA).
Emilia Soltan Anna +4 more
openaire +1 more source
Improving Medication Management for Inpatients with a Secondary Diagnosis of Parkinson Disease
AJN, American Journal of NursingABSTRACT Patients who have Parkinson disease require individualized medication regimens to optimize care. A review of the medication management of patients admitted to a tertiary care hospital with a secondary diagnosis of Parkinson disease found significant departures from the patients' home regimen.
Arlene, Boudreaux +5 more
openaire +2 more sources
Depression and Anxiety, 2000
We present a case in which the use of low dose risperidone (a potent D2 and 5-HT2 antagonist) was successful in controlling gambling behaviour secondary to dopamine agonist treatment of Parkinson's disease. Pharmacotherapeutic management of pathological gambling secondary to medical causes deserves further study.
S, Seedat +3 more
openaire +2 more sources
We present a case in which the use of low dose risperidone (a potent D2 and 5-HT2 antagonist) was successful in controlling gambling behaviour secondary to dopamine agonist treatment of Parkinson's disease. Pharmacotherapeutic management of pathological gambling secondary to medical causes deserves further study.
S, Seedat +3 more
openaire +2 more sources
Is drooling secondary to a swallowing disorder in patients with Parkinson's disease?
Parkinsonism & Related Disorders, 2008Drooling is a common manifestation in Parkinson's disease (PD). It causes psychosocial difficulties and can result in aspiration and chest infection. Previous studies point to an association between swallowing problems and sialorrhea. The aim of this study was to determine if drooling is associated with dysphagia in PD patients.
Ana Caline, Nóbrega +5 more
openaire +2 more sources
[Secondary effects of chronic treatment with levodopa in Parkinson disease].
Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2004We have analysed the side effects of levodopa preparations in patients suffering from Parkinson's disease. The study has begun in 1993. All the patients were initially admitted in the Neurological Clinic of the Recovery Hospital in Iasi, and then followed in ambulatory condition.
D, Baltag, B, Ignat, Oana-Zonia, Manole
openaire +1 more source